June 22 (Reuters) - Medadvisor Ltd (MDR) :
- COMPLETED A STRATEGIC REVIEW OF ITS OPERATIONS
- FY23 REVENUE EXPECTED TO BE IN RANGE OF A$95 MILLION TO A$97 MILLION
- PLANS TO REDUCE ITS AUSTRALIAN HEADCOUNT BY APPROXIMATELY 20% BY END OF JUNE 2023
- FY 23 EBITDA LOSS EXPECTED TO BE IN RANGE A$3.5 MILLION TO A$3.0 MILLION
- REDUCTION IN HEADCOUNT UNDERPINS ANNUAL COST SAVINGS OF CIRCA A$2 MILLION FOR FY24
- HAS POSITIONED ITSELF FOR PROFITABILITY IN FY24
- COMPANY'S CURRENT US PIPELINE IS MATERIALLY ABOVE PREVIOUS CORRESPONDING PERIOD
- Forums
- ASX - By Stock
- MDR
- News: MDR Medadvisor Says Completed Strategic Review Of Its Operations
MDR
medadvisor limited
Add to My Watchlist
1.25%
!
7.9¢

News: MDR Medadvisor Says Completed Strategic Review Of Its Operations
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $49.35M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.9¢ | $8.243K | 103.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10060 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 77963 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10060 | 0.079 |
2 | 300000 | 0.078 |
1 | 100000 | 0.076 |
2 | 66500 | 0.075 |
3 | 116554 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.083 | 77963 | 2 |
0.084 | 209999 | 3 |
0.088 | 1944 | 1 |
0.090 | 42500 | 2 |
0.091 | 100000 | 1 |
Last trade - 12.09pm 16/06/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |